Eivind Hovig
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 44
- Molecular Biology top 1%
- Gene expression and cancer classification 30
- Molecular Biology Techniques and Applications 23
- Bioinformatics and Genomic Networks 21
- Advanced biosensing and bioanalysis techniques 19
- RNA Interference and Gene Delivery 17
- Oncology top 1%
- Cancer-related Molecular Pathways 18
- Genetics top 2%
- BRCA gene mutations in cancer 18
- Biotechnology top 2%
- Co-authors
- Astrid LægreidJan KomorowskiBirgitte Smith‐SørensenTor‐Kristian JenssenOla MyklebostØystein FodstadGeir Kjetil SandveGunhild M. Mælandsmo
- Partner nations
- NorwayUnited StatesSweden
In The Last Decade
Eivind Hovig
214 papers receiving 8.7k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Cancer Research 2.3k
- Molecular Biology 6.0k
- Oncology 2.2k
- Genetics 1.1k
- Biotechnology 324
Countries citing papers authored by Eivind Hovig
This map shows the geographic impact of Eivind Hovig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eivind Hovig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eivind Hovig more than expected).
Fields of papers citing papers by Eivind Hovig
This network shows the impact of papers produced by Eivind Hovig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eivind Hovig. The network helps show where Eivind Hovig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eivind Hovig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 34 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 90 | |
| 12 | 2020 | 22 | |
| 13 | 2019 | 5 | |
| 14 | 2019 | 179 | |
| 15 | 2019 | 47 | |
| 16 | 2017 | 31 | |
| 17 | 2015 | 15 | |
| 18 | 2013 | 18 | |
| 19 | 2009 | 7 | |
| 20 | Expression of a novel factor in human breast cancer cells with metastatic potential. | 1999 | 94 |
About Eivind Hovig
Eivind Hovig is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 218 papers that have together received 8.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (44 papers), Gene expression and cancer classification (30 papers), Molecular Biology Techniques and Applications (23 papers), Bioinformatics and Genomic Networks (21 papers), Advanced biosensing and bioanalysis techniques (19 papers), BRCA gene mutations in cancer (18 papers), Cancer-related Molecular Pathways (18 papers) and RNA Interference and Gene Delivery (17 papers). The work is most often cited by research in Cancer Research (2.3k citations), Molecular Biology (6.0k citations) and Oncology (2.2k citations). Eivind Hovig has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Astrid Lægreid, Jan Komorowski, Birgitte Smith‐Sørensen, Tor‐Kristian Jenssen, Ola Myklebost, Øystein Fodstad, Geir Kjetil Sandve, Gunhild M. Mælandsmo, Monica Hollstein and C C Harris.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.